Some Justice for Henrietta Lacks
Newsweek US|August 18 - 25, 2023 (Double Issue)
Her 'immortal' cells have contributed to several major medical discoveries. Seventy-two years after her death, her family has settled a lawsuit against a biotech company
PANDORA DEWAN
Some Justice for Henrietta Lacks

ON AUGUST 1, THE FAMILY OF Henrietta Lacks, a Black woman whose cancer cells were harvested without her knowledge and used in wide-ranging medical research over many years, settled a lawsuit against biotech company Thermo Fisher Scientific. Until now, the family has not received any compensation for Lacks' contributions to medicine. Her story was the basis for the bestseller The Immortal Life of Henrietta Lacks (Crown, 2010) by Rebecca Skloot and a 2017 television movie. August 1 would have been her 103rd birthday.

"There couldn't have been a more fitting day for her to have justice, for her family to have relief," her grandson, Alfred Lacks Carter Jr., told the Associated Press. "It was a long fight-over 70 years-and Henrietta Lacks gets her day."

In the suit, filed in October 2021, the family said the company had sold Lacks' cells and sought the rights to medical products developed from research using them without the family's permission. In a joint statement, both sides in the case said the terms of the settlement were confidential, adding, "The parties are pleased that they were able to find a way to resolve this matter outside of Court and will have no further comment."

Diese Geschichte stammt aus der August 18 - 25, 2023 (Double Issue)-Ausgabe von Newsweek US.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

Diese Geschichte stammt aus der August 18 - 25, 2023 (Double Issue)-Ausgabe von Newsweek US.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

WEITERE ARTIKEL AUS NEWSWEEK USAlle anzeigen
AMERICA'S BEST LOYALTY PROGRAMS 2025
Newsweek US

AMERICA'S BEST LOYALTY PROGRAMS 2025

LOYALTY PROGRAMS HAVE BECOME A CORNERSTONE of the modern shopping experience, offering perks and rewards designed to keep customers returning for more.

time-read
3 Minuten  |
February 21, 2025
Winning the Global Game
Newsweek US

Winning the Global Game

The U.S. holds more cards than China. Whether we keep our strategic advantage depends on how we play our hand

time-read
3 Minuten  |
February 21, 2025
Solar Power
Newsweek US

Solar Power

Scientists' creation of a record-breaking \"artificial sun\" brings nuclear fusion energy a step closer to being a commercial reality

time-read
2 Minuten  |
February 21, 2025
Trump vs. Deep State
Newsweek US

Trump vs. Deep State

The president and his efficiency chief Elon Musk have brought in a wave of policies affecting federal employees' jobs. Government workers spoke to Newsweek about the impact

time-read
6 Minuten  |
February 21, 2025
MAD ABOUT THE GIRL
Newsweek US

MAD ABOUT THE GIRL

AS RENÉE ZELLWEGER REPRISES THE ICONIC CHARACTER, BRIDGET JONES' CREATOR - AND MILLIONS OF FANS, COULDN'T BE HAPPIER

time-read
10+ Minuten  |
February 21, 2025
Armed and Dangerous
Newsweek US

Armed and Dangerous

A Ukrainian colonel reveals how North Korean soldiers compared with their Russian allies

time-read
4 Minuten  |
February 21, 2025
Patrick Gibson
Newsweek US

Patrick Gibson

WHEN YOU TAKE ON A ROLE THAT SOMEBODY ELSE MADE FAMOUS, IT'S not easy.

time-read
2 Minuten  |
February 21, 2025
The AI Will See You Now
Newsweek US

The AI Will See You Now

A light-hearted study into artificial intelligence's ability to perform cognitive tasks has raised questions around the roles of AI and doctors in health care

time-read
6 Minuten  |
February 21, 2025
Jasmin Savoy Brown
Newsweek US

Jasmin Savoy Brown

SHOWTIME'S YELLOWJACKETS IS REALLY TWO shows in one.

time-read
2 Minuten  |
February 21, 2025
BIOTECH: Blood, Sweat and Tears
Newsweek US

BIOTECH: Blood, Sweat and Tears

Nine years in the making, Truvian's quick tabletop blood test promises to deliver where Theranos famously couldn't

time-read
6 Minuten  |
February 14, 2025